Reactive oxygen species and not lipoxygenase products are required for mouse B-lymphocyte activation and differentiation

International Journal of Immunopharmacology

Volumn 16, Issue 7, 1994, Pages 533-546

  Fedyk, Eric R ^a   Phipps, Richard P ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; 2 CYCLOPENTYL 2 [4 (2 QUINOLINYLMETHOXY)PHENYL]ACETIC ACID; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 5,8,11 ICOSATRIYNOIC ACID; 5,8,11,14 ICOSATETRAYNOIC ACID; ALPHA METHYL 6 (2 QUINOLYLMETHOXY) 2 NAPHTHYLACETIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; BUTYLCRESOL; ESCULETIN; IMMUNOGLOBULIN M ANTIBODY; LIPOPOLYSACCHARIDE; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; NORDIHYDROGUAIARETIC ACID; REACTIVE OXYGEN METABOLITE; THIOUREA;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; B LYMPHOCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; B-LYMPHOCYTES; CELL DIFFERENTIATION; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDES; LIPOXYGENASE; LIPOXYGENASE INHIBITORS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; REACTIVE OXYGEN SPECIES; SPLEEN; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028298757     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/0192-0561(94)90105-8     Document Type: Article

References (54)

1. Inhibitory effect of an antioxidant, butylated hydroxyanisole, on the primary in vitro immune response (39656)
2. Use of an in vitro antibody-producing system for recognizing potentially immunosuppressive compounds
3. Eicosanoids and rheumatology: inflammatory and vascular aspects
4. 2 induces apoptosis in immature normal and malignant B-lymphocytes
5. Effect of antioxidants on primary alloantigen-induced T-cell activation and proliferation
6. 4 and the immune system
7. Frequency of B-lymphocytes responsive to anti-immunoglobulin
8. Inhibition of murine T-cell responses by anti-oxidants: the targets of lipo-oxygenase pathway inhibitors
9. 4 potentiates the expression and release of FcεRII/CD23 and proliferation and differentiation of human B-lymphocytes induced by IL-4
10. Peptidoglycan and lipopolysaccharide bind to the same binding site on lymphocytes
11. 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors
12. Enhanced synthesis of cysteinyl leukotrienes in polytraumatized patients with and without adult respiratory distress syndrome
13. The generation of oxygen radicals: a positive signal for lymphocyte activation
14. L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid, a novel, orally active leukotriene biosynthesis inhibitor
15. Selective feed-back inhibition of the 5-lipoxygenation of arachidonic acid in human T-lymphocytes
16. Eicosanoid metabolism by lymphocytes: do all human cells generate eicosanoids?
17. Role of free radicals and catalytic metal ions in human disease: an overview
18. Superoxide generation by EBV-transformed B-lymphocytes. Activation of IL-1β, TNF-α and receptor independent stimuli
19. Mode of action of the new selective leukotriene synthesis inhibitor Bay X 1005 {(R)-2-[4-(Quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid} and structurally related compounds
20. In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin
21. Interference with oxidative processes inhibits proliferation of human peripheral blood lymphocytes and murine B-lymphocytes
22. Kinetics of photoperoxidation of arachidonic acid: molecular mechanisms and effects of antioxidants
23. On the expression and regulation of 5-lipoxygenase in human lymphocytes
24. 5-Lipoxygenase is not essential in macrophage-mediated oxidation of low-density lipoprotein
25. Specific endotoxic lipopolysaccharide-binding receptors on murine splenocytes: III. Binding specificity and characterization
26. Inducible nuclear expression of NFкB in primary B-cells stimulated through the surface Ig receptor
27. 245 components by human tonsillar B-lymphocytes and B-cell lines
28. Protein kinase C mobilization in B-lymphocytes: differential isoenzyme translocation upon activation
29. Transcriptional analysis of inhibition of lipopolysaccharide response by anti-IgM
30. Opposite effects of lipopolysaccharide and dextran sulfate on membrane phospholipid metabolism of murine B-lymphocytes
31. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays
32. 5-Lipoxygenase: properties, pharmacology, and the Quinoliny(bridged)aryl class of inhibitors
33. Inhibitory effect of Esculetin on lipoxygenase and leukotriene biosynthesis
34. Inhibition of leukotriene C and leukotriene D biosynthesis
35. 2 and hydroxyarachidonic acids in purified human lymphocytes in the presence and absence of PHA
36. Interactions of a series of coumarins with reactive oxygen species: scavenging of superoxide, hypochlorous acid and hydroxyl radicals
37. Human 5-lipoxygenase contains an essential iron
38. The potential role of leukotrienes in bronchial asthma
39. Lipoxygenase metabolites of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cells
40. Iron, an essential component of lipoxygenase
41. Differential effects of putative inhibitors of cytosolic and membrane associated platelet lipoxygenase
42. Signal transduction in B-cells
43. 2 and cAMP inhibit B-lymphocyte activation simultaneously promote IgE and IgG1 synthesis
44. Leukotriene antagonists and synthesis inhibitors: use in psoriasis and other skin disease
45. Comparative effect of indomethacin, acetylenic acids, 15-HETE, nordihydroguiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets
46. A role for oxygen radicals as second messengers
47. Dithiocarbamates as potent inhibitors of nuclear factor кB activation in intact cells
48. Evidence for 5-lipoxygenase activity in human B-cell lines: a possible role for arachidonic acid metabolites during B-cell signal transduction
49. 2, immune complexes and IFN-γ
50. 2 and IFN-γ
51. Incorporation of 5,8,11,14-eicosatetraynoic acid (ETYA) into cell lipids: competition with arachidonic acid for esterification
52. Leukotriene B4 enhances activation, proliferation, and differentiation of human B-lymphocytes
53. Arachidonate 12-lipoxygenase purified from porupine leukocytes by immunoaffinity chromatography and its reactivity with hydroperoxyeicosatetraenoic acids